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Single-walled carbon nanotubes (SWCNTs) have been proposed to have great therapeutic potential. SWCNTs conjugated with
drugs or genes travel in the systemic circulation to reach target cells or tissues following extravasation from microvessels although
the interaction between SWCNT conjugates and the microvascular endothelial cells (ECs) remains unknown. We hypothesized that
SWCNT-DNA conjugates would be taken up by microvascular ECs and that this process would be facilitated by SWCNTs compared
to facilitation by DNA alone. ECs were treated with various concentrations of SWCNT-DNA-FITC conjugates, and the uptake and
intracellular distribution of these conjugates were determined by a confocal microscope imaging system followed by quantitative
analysis of fluorescence intensity. The uptake of SWCNT-DNA-FITC conjugates (2 µg/mL) by microvascular ECs was significantly
greater than that of DNA-FITC (2 µg/mL), observed at 6 hrs after treatment. For the intracellular distribution, SWCNT-DNAFITC conjugates were detected in the nucleus of ECs, while DNA-FITC was restricted to the cytoplasm. The fluorescence intensity
and distribution of SWCNTs were concentration and time independent. The findings demonstrate that SWCNTs facilitate DNA
delivery into microvascular ECs, thus suggesting that SWCNTs serving as drug and gene vehicles have therapeutic potential.

1. Introduction
Emerging evidence supports the great potential of nanotechnology for medical applications with respect to diagnosis
and therapeutic treatment of disease [1, 2]. Most recently,
Welsher et al. reported promising findings by using a second
near-infrared window imaging system in real time [3].
They found that single-walled carbon nanotubes (SWCNTs),
intravenously injected into mice, were distributed throughout the body and reached a steady level approximately 30 sec
after injection. Meanwhile, the liver, lungs, muscles, and
kidneys all generated constant signal, indicating consistent
blood flow in these organs. These findings indicate that
SWCNTs are able to traverse the microvascular barrier
into surrounding tissues. Furthermore, they reported that
no toxic side eﬀects were detected by necropsy, histology,
and blood chemistry measures in those mice three months
after receiving SWCNT injection [4]. The data support the

promising potential of SWCNTs in medical applications,
yet the mechanism(s) underlying extravasation of SWCNTs
remains unknown.
Understanding how SWCNTs interact with microvascular endothelial cells (ECs) is critical for developing therapeutic treatments using highly eﬃcient gene/drug delivery
systems due to the pivotal roles of microvascular ECs in the
structure and function of the microvasculature. Vascular ECs
are in the vanguard for exposure to blood-born elements
because they serve as the lining surface of blood vessels. In
addition to being a major component of the microvascular
wall, microvascular ECs dynamically mediate a variety of
vascular functions, including EC-dependent vasomotion,
thrombosis formation, vascular inflammation, and vascular
exchange (permeability). Most drugs and genes need to be
delivered to their target tissues by the systemic circulation
after they are absorbed or injected into the blood stream.
Subsequently, these drugs and genes traverse the vascular
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barrier and arrive at the surrounding tissues, a situation
referred to as solute exchange. Importantly, all solute
exchanges between circulating blood and metabolizing tissue
as well as angiogenesis occur at the level of microvessels.
SWCNT uptake by microvascular ECs is an initial step
in the process of drug and gene delivery into either vascular
ECs or parenchymal cells. For all the therapeutic treatments
with a strategy of specifically targeting microvascular ECs
(e.g., antiangiogenesis to reduce tumor growth), SWCNTs
conjugated with molecular cargo need to be transported into
microvascular ECs. For the treatments targeting parenchymal cells (e.g., tumor cells), the SWCNT-drug conjugates
must interact with microvascular ECs in the process of
extravasation. In general, there are two pathways (paracellular and transcellular) responsible for large molecules to pass
through the vascular barrier. Because SWCNTs often have
lengths from hundreds of nanometers to several micrometers and are considered to be in the same size range as
macromolecules, we predict that SWCNT-DNA conjugates
will predominantly traverse the microvascular barrier via
the transcellular pathway (transcytosis) [5]. Entering the
microvascular ECs is an initial step in the process of transcytosis. Therefore, understanding the interaction between
SWCNTs and microvascular ECs is critical for developing
advanced drug and gene delivery systems using SWCNTs. To
date, the eﬀect of carbon nanotubes on microvascular ECs
remains unknown.
Only a limited number of studies exist concerning the
interactions between SWCNTs and vascular ECs [6, 7].
Moreover, large vascular ECs, including HUVECs (human
umbilical vein endothelial cells) or aortic ECs [8], were typically used for these studies. Heterogenic properties between
large vascular and microvascular ECs [9, 10], however,
should be considered. It is inappropriate to extrapolate the
findings from studies using large vascular to microvascular
ECs. Appropriately, this is the first study, to our knowledge,
designed to determine the interactions between SWCNTs
and microvascular ECs. We hypothesized that SWCNT-DNA
conjugates would be taken up by microvascular ECs and
that this process would be facilitated by SWCNTs compared
with DNA alone. We employed a biocompatible SWCNTDNA conjugate [11, 12] labeled with FITC fluorophore
(SWCNT-DNA-FITC) and primary cultured microvascular
ECs derived from rat skeletal muscles [13] to study the interactions between them. We report here that SWCNT-DNAFITC conjugates were detected in the nuclei of microvascular
ECs at 6 hrs after the cells were exposed to the conjugates (at
a concentration as low as 2 µg/mL), while DNA-FITC alone
was restricted to the cytoplasm under identical conditions.
Quantitative analysis of confocal images provided evidence
to support the hypothesis that SWCNTs facilitated DNA
uptake by microvascular ECs.

2. Materials and Methods
2.1. Preparation of SWCNT-DNA-FITC Conjugates. To prepare an aqueous SWCNT solution, 1 mg of SWCNT powder
(BuckyUSA Company) was dispersed in 1 mL ssDNA (5
CCT GAG CCA TGA TCA AAC CTG TGC AGT) or DNA-
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FITC (5 FITC CCT GAG CCA TGA TCA AAC CTG TGC
AGT, Alpha DNA, 1 mg/mL) solution. The suspension was
sonicated on ice for 60 minutes to avoid the degradation
of DNA molecules and then centrifuged at 120,000 g for
60 minutes. After centrifugation, the supernatant containing
individual SWCNTs was decanted, whereas the precipitates
containing catalyst particles, bundled nanotubes, and amorphous carbon debris were discarded [11, 12].
2.2. Rat Microvascular ECs. Microvascular ECs were isolated
from abdominal skeletal muscles of rats, cultured with M199
medium containing essential supplements, and characterized
as previously described [13]. Briefly, the excised abdominal
skeletal muscles were digested with an enzyme solution
consisting of dispase (0.12 mg/mL; Worthington, Lakewood,
NJ), trypsin (0.12 mg/mL; Invitrogen, Carlsbad, Calif), collagenase type II (0.84 mg/mL), and bovine serum albumin
(BSA; 1.62 mg/mL) in M199 medium. Microvascular ECs
were isolated by using Dynabeads (Dynal, Brown Deer, Wis)
coated with Griﬀonia simplicifolia lectin and then cultured.
The culture medium consisted of M199 medium supplemented with 5 mg/mL endothelial growth supplement,
0.1 mg/mL glutamine, 10000 unit/mL antibiotic/antimycotic
(Gibco, Carlsbad, Calif), 5 unit/mL heparin sodium (Sigma
Aldrich, St. Louis, Mo), and 20% Fetal Bovine Serum (FBS;
HyClone Lab, Inc. Logan, Utah) for the first two passages,
then 10% FBS afterward.
2.3. Nanoparticle Distribution in Primary Cultured Microvascular ECs. ECs were seeded on gelatin (0.2%)-coated LabTek II Chamber Slides with a cell density of 104 cells/cm2 .
Grown to approximately 80% confluency in 48 hrs, cells
were treated with either SWCNT-DNA-FITC or DNA-FITC
solution at various concentrations. After various incubation
times, ECs were fixed by using 2% paraformaldehyde for
10 min at 37◦ C and subsequently stained with 1% DAPI
(0.5 µg/mL) for 1 min at room temperature. Dulbecco’s
phosphate buﬀered saline (DPBS) containing 0.05% Tween20 (DPBST-20) was used to wash the cells following fixation
and staining procedures.
2.4. Spinning Confocal Microscopy. The microvascular ECs
were examined with an Olympus IX81 inverted microscope
equipped with a laser light source, motorized stage capable
of 1 µm z-axis increments, spinning confocal box (Yokogawa X1M1L), and electron multiplying EM-CCD camera
(Hamamatsu, ImagEM). All the images were acquired with a
60X oil immersion objective lens and identical exposure time
and appropriate filter setup controlled by Slidebook software
(v5.0).
2.5. Quantification of Fluorescence Intensity. Fluorescence
intensity of SWCNT-DNA-FITC or DNA-FITC in microvascular ECs was quantitatively analyzed by using Image-Pro
Plus 6.0 software. Briefly, a background signal level for each
image was set using the average optical density (OD) value
from four regions (each region contains >15,000 square
pixels), where no cells or any fluorescence were detected.

Journal of Nanotechnology

3

2 µg/mL SWCNT-DNA-FITC for 24 hr
a

b

c

d

f

g

h

i

2 µg/mL DNA-FITC for 24 hr

e

(A)

j

k

l

m

o

p

q

r

n

40 µm
(B)

y

10 um grid
(C)

z

x

Figure 1: A series of z-stack images demonstrating diﬀerential distribution of SWCNT-DNA-FITC (2 µg/mL) versus DNA-FITC (2 µg/mL)
conjugates in microvascular ECs: (A) (a to i), representative optical section series of SWCNT-DNA-FITC conjugates in microvascular
ECs at 24 hrs post incubation; (B) (j to r), representative optical section series of DNA-FITC present in microvascular ECs at 24 hrs post
incubation; (C), sample 3-D image from a video (supplemental materials) acquired from ECs by a spinning confocal imaging system 48 hrs
after incubation with SWCNT-DNA-FITC (2 µg/mL). The scale bar in (B) (o) is applicable to all images (a–r).

Consequently, each OD value obtained from this image was
subtracted from the background OD. To assess fluorescence
intensity of SWCNT-DNA-FITC or DNA-FITC within a
cell, 5 areas of interest (AOI) from each cell were selected.
The average OD value from 5 identical AOI within a cell
represented the fluorescence intensity for this cell. Each
image OD value, calculated as the average OD from up to
5 cells per image, represented one experiment (n = 1). The
criteria for cell and AOI selection were as follows: (1) cells
with well-defined cell shape and the strongest signal; (2) each

AOI (100∼200 pixels2 in surface area) with the brightest area
in the cell body excluding cell processes.
2.6. Statistical Analysis. All values are presented as mean ±
SEM. GraphPad Prism 5 software was employed for statistical
analysis. Comparisons between two groups, SWCNT-DNAFITC versus DNA-FITC, at given concentrations and specific
time points, were analyzed by unpaired student’s t-test.
Values of P < 0.05 were accepted as being statistically significant.
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3. Results and Discussion

3.2. Quantitative Evidence for the Facilitation of DNA Uptake
by Microvascular ECs through SWCNTs. To quantitatively
assess the amount of DNA conjugated to SWCNTs taken up
by microvascular ECs, we analyzed the fluorescence intensity
of SWCNT-DNA-FITC conjugates by measuring OD values.
For this purpose, images of microvascular ECs, treated with
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80
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3.1. Uptake and Intracellular Distribution of SWCNT-DNA
Conjugates in Microvascular ECs. To investigate the interactions between microvascular ECs and SWCNTs, we isolated,
cultured, and characterized primary microvascular ECs from
rat skeletal muscles. Importantly, the results derived from
this in vitro study using primary cultured microvascular ECs
will guide us to investigate further the eﬃcacy of the drug- or
gene-SWCNT delivery system in species- and tissue-matched
intact microvessels in living animals [13, 14].
Individual short SWCNTs with 800–900 nm in average
length [11, 12] were used in the SWCNT-DNA-FITC conjugates. To identify the eﬀect of SWCNTs on DNA uptake
by microvascular ECs, the cells were treated with SWCNTDNA-FITC (2 µg/mL) and DNA-FITC (2 µg/mL), respectively. The images of microvascular ECs exposed to SWCNTDNA-FITC conjugates for 24 hrs were acquired by a spinning
scanning confocal imaging system and demonstrated in
Figure 1. SWCNT-DNA-FITC conjugates appeared to be localized in the EC nuclei, a conclusion determined by the
position, shape, and area of FITC fluorescence as shown in
a set of z-stack images in Figure 1(A). In contrast, DNAFITC was dispersed weakly in the cytoplasm of microvascular
ECs (Figure 1(B)) and often found on or close to the
plasma membrane (Figure 2(a)), but not in the nucleus. The
nuclear localization of SWCNTs was also manifested in a 3D
projection image (Figure 1(C)) and a supplementary z-scan
video (see Supplementary Materials available online at doi:
10.1155/2012.196189). The results support our hypothesis
that DNA conjugated to SWCNTs is taken up by microvascular ECs. In view of the finding that SWCNT-DNA-FITC,
but not DNA-FITC, accumulates in the nucleus, it is likely
that SWCNTs play a facilitating role in delivering the DNA
to the nuclei of microvascular ECs. Thus, our results suggest
that SWCNTs could be used as vectors for gene delivery to
microvascular EC targets.
SWCNTs used in this study did not appear to have
adverse eﬀects on cellular morphology and proliferation,
observations supported by the previous studies using astrocytoma cells [11, 12]. However, the formation of aggregates
was observed in the culture medium following the addition of SWCNT-DNA-FITC solution for the cell treatment
groups, but not DNA-FITC solution for the control groups.
The aggregates adhered to the surfaces of microvascular ECs
even after fixation and washing procedures. The morphology
and numbers of microvascular ECs treated with SWCNTDNA-FITC conjugates at various concentrations within
48 hrs did not diﬀer with control ECs treated with DNAFITC alone (data not shown), assessed by a transmitted light
imaging system. The functional and molecular influence of
the aggregations on microvascular ECs remains to be studied.
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Figure 2: Distribution and fluorescence intensity of SWCNT-DNAFITC (2 µg/mL) and DNA-FITC (2 µg/mL) at various time intervals
within 48 hrs. (a) Representative projection images suggest that
SWCNT-DNA-FITC conjugates are distributed in microvascular EC
nuclei (lower panel); DNA-FITC appears to be restricted to the
cytoplasm (upper panel). (b) SWCNT-facilitated DNA transport
into microvascular ECs. Fluorescence intensity was quantitatively
assessed by measuring optical density of confocal images as
described in Materials and Methods. The P-values less than 0.05
and 0.01 are expressed as ∗ and ∗∗ , respectively (n = 3–11). The
scale bar is applicable to all images.

SWCNT-DNA-FITC conjugates or DNA-FITC at various
concentrations (2, 4, and 10 µg/mL) for up to 48 hrs (at
6, 12, 24, and 48 hrs), were acquired. Interestingly, the OD
value of SWCNT-DNA-FITC conjugate in microvascular ECs
registered approximately a 3∼4-fold increase compared to
that of DNA-FITC after incubation at a concentration of
2 µg/mL (33.5 ± 6.3 (n = 4) versus 11.3 ± 3.8 (n = 3) at 6 hrs;
47.0 ± 3.4 (n = 6) versus 14.8 ± 3.4 (n = 6) at 12 hrs; 40.4 ± 3.3
(n = 7) versus 12.7 ± 1.0 (n = 6) at 24 hrs; 53.7 ± 5.4 (n = 6)
versus 13.2 ± 2.2 (n = 11) at 48 hrs) as shown in Figure 2.
As microvascular ECs were treated with SWCNT-DNA-FITC
conjugates at a concentration of 10 µg/mL, the uptake of
SWCNT-DNA-FITC by microvascular ECs was also found to
be greater than that of DNA-FITC (40.3 ± 5.5 (n = 4) versus
12.7 ± 2.2 (n = 3) 6 hrs; 46.7 ± 2.7 (n = 3) versus 2.3 ± 0.9
(n = 3) at 12 hrs; 38.7±7.6 (n = 6) versus 18.3±2.9 (n = 6) at
24 hrs; 37.6 ± 4.5 (n = 12) versus 16.5 ± 1.8 (n = 6) at 48 hrs)
(Figure 3). These data demonstrate again that SWCNTs
facilitate DNA uptake by microvascular ECs. However, this
action was neither concentration dependent within the
tested range from 2 µg/mL to10 µg/mL (Figure 4(a)) nor
time dependent within the periods from 6 hrs to 48 hrs
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Figure 3: Intracellular compartmentalization and fluorescence
intensity of SWCNT-DNA-FITC (10 µg/mL) and DNA-FITC
(10 µg/mL) in microvascular ECs and observed at 6, 12, 24, and
48 hrs. (a) Representative projection images acquired by confocal
microscopy; (b) Quantitative analysis of fluorescence intensity of
SWCNT-DNA-FITC and DNA-FITC conjugates. The P-values less
than 0.05 and 0.01 are expressed as ∗ and ∗∗ , respectively (n = 3–
12). The scale bar is applicable to all images.

(Figure 4(b)). Although there were no major diﬀerences
in the fluorescence intensity of internalized SWCNT-DNAFITC conjugates over the time course and among treatments
with various concentrations of SWCNTs, we observed a trend
that 2 µg/mL SWCNTs combined with 12 hrs incubation
yields optimal, eﬃcacious delivery (Figure 4). Therefore,
for future studies, we recommend that microvascular ECs
be treated with 2 µg/mL SWCNT-DNA-FITC for 12 hrs in
order to understand mechanisms by which SWCNTs enter
microvascular ECs.
The mechanisms underlying SWCNT uptake by microvascular ECs remain unknown at the present time. In
general, there are three ways by which extracellular molecules
enter a cell: simple diﬀusion, carrier-mediated transport
(e.g., ion channels or transporters), and endocytosis. SWCNTs, macromolecules, are internalized into the intracellular compartment through endocytosis, evidenced by several studies using diﬀerent types of mammalian cells [6,
15]. Endocytosis can be further categorized as pinocytosis, phagocytosis, and clathrin- and caveolae-mediated endocytosis. Pinocytosis and phagocytosis are main pathways for
macrophages, while clathrin- and caveolae-mediated pathways are used by most cells including endothelial cells [16,
17]. Kam found that the uptake of SWCNT-DNA conjugates by two tumor cell lines, HeLa and HL60 tumor cells,

was attenuated by disrupting the formation of clathrincoated vesicles. The evidence supports the internalization
of SWCNT-DNA via clathrin-mediated endocytotic mechanism [15]. Compared with Kam’s study, the current one
used primary skeletal muscle microvascular ECs derived
from the exchange microvessels to investigate the uptake
of SWCNT-DNA. To our best knowledge, diﬀerent types
of cells have heterogeneous functions, structures, and
mechanisms, even within vascular endothelial cells across
vascular trees [10]. Lining the inner side of exchange microvessels, microvascular ECs used in the current study
engage in transcytosis to allow macromolecules traversing
the microvascular barrier. Endothelial cells possess more
caveolae than clathrin-coated pits. The number of caveolae is the highest in capillary endothelial cells, compared
with arteries, arterioles, venules, and veins, particularly in
heart, lung, and skeletal muscle [10]. In the process of
transcytosis, caveolae-mediated endocytosis plays an important role as an initial step of the transcellular pathway
across endothelial cells [5, 10, 18]. In addition to clathrinand caveolae-mediated endocytosis, Muro and coworkers
demonstrate that nanoparticles, composed of polystyrene
latex microspheres, were taken up by HUVECs via the celladhesion-molecule- (CAM-) mediated endocytotic process.
The CAM-mediated endocytosis was revealed by colocalization of nanoparticles and endocytotic markers, including
early endosome antigen [19] and Na+/H+ exchange ion
channel (associated with CAM-mediated endocytosis) [20].
It was noted that Muro’s study used HUVEC, while we
used microvascular EC besides diﬀerent nanoparticles. In
addition, studies using a mathematical model to calculate the
energy cost needed for carbon nanotubes piercing through
the bilayer of the plasma membrane demonstrate indirectly
that the most likely pathway of carbon nanotube delivery
into cells is by endocytosis due to a substantial energy
requirement [21].
So far, the answer to whether or not microvascular ECs
take up SWCNTs by endocytotic processes and what endocytotic mechanisms are employed remain to be determined.
Understanding these mechanisms requires characterizing
the spatial-temporal relationship between SWCNTs and
microvascular ECs.
We found that the fluorescence intensity of the SWCNTDNA-FITC conjugate in microvascular ECs was concentration and time independent. These results indicate that
SWCNTs do not accumulate over time in microvascular ECs
and that the level of SWCNTs in cells reached a plateau
6 hrs after incubation. Since SWCNTs are highly stable
structures [6], we predict that microvascular ECs are not
able to degrade internalized SWCNTs via lysosomes but
expel them over time (exocytosis). The process, in which
molecules, in this case of SWCNTs, undergo endocytosis and
then exocytosis, is referred to as transcytosis. Transcytosis
is one of the pathways by which macromolecules, such as
drugs and large proteins, pass through microvascular barriers
[5, 22]. This concept has significant implications in terms
of using SWCNTs as carriers to deliver drugs/genes into
parenchymal cells after SWCNTs move from microvessels
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SWCNT uptake by microvascular ECs was concentration
and time independent. These data suggest that SWCNTs
may provide impressive therapeutic potential as vehicles for
delivery of drugs or genes to either microvascular ECs or parenchymal cells.
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Figure 4: Quantity of SWCNT-DNA-FITC conjugates retained in
EC nuclei is concentration- and time-independent. (a) Relationship
between quantity of SWCNTDNA-FITC in the nuclei and the
concentrations of SWCNT-DNA-FITC conjugates; (b) Time-course
of fluorescence intensity of SWCNT-DNA-FITC in the nuclei of
microvascular ECs.

into the surrounding interstitium. However, the timing of
DNA release from SWCNT-DNA conjugates, critical information for designing a drug delivery system with high eﬃcacy, remains to be studied.

4. Conclusions
This study is the first to demonstrate that SWCNT-DNA
conjugates are taken up by microvascular ECs. We observed
that intracellular fluorescence intensity of SWCNT-DNAFITC in microvascular ECs was greater than the fluorescence
intensity of DNA-FITC alone, suggesting that the uptake was
facilitated by SWCNTs. In addition, SWCNT-DNA conjugates were most likely localized in the nuclei of microvascular
ECs, whereas DNA was distributed in the cytoplasm. The
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